The Department of Health – Abu Dhabi, the organizational authority for the health care sector in the emirate, and M42, the world leading health company supported by artificial intelligence, technology and genome sciences, and “Burhailth”, the largest hospital and health guarantee group in the Middle East region, announced a partnership with a partnership with “Jimpio Thurabiotics”, the innovative global biotechnology company committed to developing genetic treatments for diseases Rare. The announcement of the partnership came after the meeting, which was held within the activities of the World Innovation Organization in Biotechnology 2025 in Boston, America, and the senior leaders of the company “Jimpio” and leadership figures in the health and life sciences system
source
